[Comparison of mexiletine and dihydroquinidine in the treatment of ventricular asystolic arrhythmia].
Accettura
D
D
De Toma
L
L
Lagioia
R
R
Mastropasqua
F
F
Mangini
S G
SG
Scrutinio
D
D
Rizzon
P
P
D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001247:Asthenia / Q000139:chemically induced; D005117:Cardiac Complexes, Premature / Q000188:drug therapy* / Q000209:etiology; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008801:Mexiletine / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D011437:Propylamines / Q000627:therapeutic use*; D011802:Quinidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011897:Random Allocation
D011437:Propylamines; D008801:Mexiletine; C014486:hydroquinidine; D011802:Quinidine
Confronto tra mexiletina e diidrochinidina nel trattamento dell'aritmia extrasistolica ventricolare.